[Asia Economy Reporter Gong Byung-sun] Celltrion announced on the 26th that it has signed a supply reservation contract for the COVID-19 antibody treatment Regkirona worth 48.5 billion KRW with its affiliate Celltrion Healthcare.
This amounts to approximately 2.62% of recent sales revenue.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
